Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.

Kimberly GeigerMarkus JoergerMax RoesslerKarina HettwerChristoph RitterKirsten SimonSteffen UhligStefan Holdenrieder

Published in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2024)

STM at the time of first radiological staging and pretherapeutic CA15-3, CA125 are predictive for first-line treatment response and highly prognostic in patients with advanced NSCLC.

Keyphrases

end stage renal disease
newly diagnosed
small cell lung cancer
ejection fraction
chronic kidney disease
peritoneal dialysis
lymph node
patient reported outcomes
mesenchymal stem cells
advanced non small cell lung cancer